A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Public ClinicalTrials.gov record NCT05764161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis
Study identification
- NCT ID
- NCT05764161
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Interventions
- Ruxolitinib Cream Drug
- Vehicle Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2023
- Primary completion
- Dec 29, 2024
- Completion
- Nov 3, 2025
- Last update posted
- Dec 17, 2025
2023 – 2025
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama At Birmingham | Birmingham | Alabama | 35233 | — |
| Northwest Arkansas Clinical Trials Center | Arkansas City | Arkansas | 72758 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Clinical Science Institute Clinical Research Specialists Inc | Santa Monica | California | 90404 | — |
| Cura Clinical Research | Sherman Oaks | California | 91403 | — |
| Ars - Maitland Clinical Research Unit | Orlando | Florida | 32819 | — |
| Marietta Dermatology the Skin Cancer Center Marietta | Marietta | Georgia | 30060-1047 | — |
| The South Bend Clinic Main Campus | South Bend | Indiana | 46617 | — |
| Axon Clinical Research | Baltimore | Maryland | 21237 | — |
| Activmed Practices Research, Llc Beverly | Beverly | Massachusetts | 01915 | — |
| Oakview Dermatology | Athens | Ohio | 45701 | — |
| Aventiv Research Inc-Dublin | Dublin | Ohio | 43016 | — |
| Wright State Physicians, Inc. | Fairborn | Ohio | 45324 | — |
| University of Pittsburgh Medical Center Upmc Dermatology Clinic Oakland Falk Medical Building | Pittsburgh | Pennsylvania | 15232 | — |
| Dermdox Center For Dermatology | Sugarloaf | Pennsylvania | 18249 | — |
| Dermresearch, Inc. | Austin | Texas | 78759 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05764161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05764161 live on ClinicalTrials.gov.